- TG Therapeutics (TGTX) is scheduled to announce Q4 earnings results on Thursday, February 26th, before market open.
- The consensus EPS estimate is $0.33 and the consensus revenue estimate is $193.34M (+78.7% Y/Y).
- Over the last 3 months, EPS estimates have seen 3 upward revisions and 1 downward. Revenue estimates have seen 7 upward revisions and 0 downward.
TG Therapeutics Q4 2025 Earnings Preview
